AstraZeneca will pay $425 million to settle lawsuits on behalf of consumers who suffered kidney injuries while using its heartburn medications Nexium and Prilosec. AstraZeneca in a statement said ...

Oct. 3 (UPI) --Multinational pharmaceutical maker AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company's heartburn ...

A former AstraZeneca Pharmaceuticals LP sales worker adequately alleged she was fired after the company rejected her request ...

The lawsuit surrounded AstraZeneca’s blockbuster lung cancer ... with three of its own patent infringement suits. The latest settlement was in 2022, blocking Alembic Pharmaceuticals from making ...

AstraZeneca was sued on Aug. 26 in Pennsylvania Eastern District Court over alleged employment discrimination. The court case was brought by the Gold Law Firm on behalf of a former senior user ...

AstraZeneca unit and Samsung Bioepis resolve their patent dispute over a biosimilar | Settlement follows FDA approval for the ...

The lawsuits against AstraZeneca Families of individuals affected by adverse vaccine reactions continue to pursue legal recourse against AstraZeneca and the Serum Institute of India. Venugopalan ...

Drugs giant AstraZeneca has agreed to settle a raft of legal claims over ... GSK said in June that it had settled a lawsuit relating to Zantac – known chemically as ranitidine – and that ...

After a landmark $US425 million settlement in the United States, the drugs are being investigated in Australia over alleged ...

India's confirmed mpox case from an older virus strain, MBX Biosciences' US IPO plans, AstraZeneca's trial results of a lung ...

A former West Covina Unified School District principal has reached a “conditional” settlement in her discrimination lawsuit against the Los Angeles-area school district, according to the San Gabriel ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...